Gosset British Patient Capital General Information
British Patient Capital is the UK’s largest domestic investor in venture and venture growth capital. It manages over £3 billion in assets and supports high-growth potential UK businesses—especially those in innovative sectors like life sciences and breakthrough technologies—by investing through funds, co-investments, and direct investments. Since its launch in 2018 as a subsidiary of the government-owned British Business Bank plc, BPC has made significant commitments to both funds and companies that are advancing new healthcare technologies[2][5][7].
Contact Information
United Kingdom
Drug Pipeline
No pipeline data available
Key Partnerships
Invests alongside major global investors such as Novo Holdings, Abingworth, Cancer Research Horizons, Eli Lilly & Company., Has committed capital to leading VC funds like SV Health Investors’ Impact Medicine Fund
British Patient Capital Funding
No funding data available